Dietary Intervention for Improving Human Health: Acute Disorders

Prebiotics: Development & Application

Volumn , Issue , 2012, Pages 157-179

  Brück, Wolfram M ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

C. difficile with traditional prebiotics, hindering recovery with antibiotic use; Dietary intervention in improved human health, acute disorders; Dietary materials entering intestine, candidate prebiotic; Enhanced functionality, altering gut pathogenesis; EPEC infections, A E histopathology; FOS and inulins, occurring naturally in plants; Humans and microorganisms, skin, mouth and GI; Prebiotic as nondigestible ingredient, beneficially affecting host; Prebiotics and design parameters

Indexed keywords

EID: 77955635837     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470023150.ch7     Document Type: Chapter

References (104)

1. Altekruse, S. F., Cohen, M. L. and Swerdlow, D. L. (1997) Emerging foodborne diseases. Emerging Infect. 3, 285-293.
2. Asahara, T., Nomoto, K., Shimizu, K., Watanuki, M. and Tanka, R. (2001) Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic admmistration of bifidobacteria and tansgalactosylated oligosaccharides. J. Appl. Microbiol. 91 (6), 985-996.
3. Ballongue, J., Schumann, C. and Quignon, P. (1997) Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand. J. Gastroenterol. 32, 41-44.
4. Björksten, B., Naaber, P., Sepp, E. and Mikelsaar, M. (1999) The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29 (3); 342-346.
5. Blehaut, H., Saint-Marc, T. and Touroine, J. L. (1992) Double blind trial of Saccharomyces boulardii in AIDS related diarrhea. International Conference on AIDS/Third STDWorld Congress, Abstract 2120.
6. Born, P., Lersch, C., Zimmerhackl, B. and Classen, M. (1993) The Saccharomyces boulardii therapy of HIV-associated diarrhea. Dtsch Med. Wochenschr. 118 (20), 765.
7. Boudeau, J., Glasser, A. L., Julien, S., Colomberl, J. F. and Darefeuille-Michaud, A. (2003) Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. Aliment. Pharmacol Ther. 18 (1), 45-56.
8. Bovee-Oudenhoven, I. M., ten Bruggencate, S. J., Lettink-Wissink, M. L. and van der Meer, R. (2003) Dietary fructo-oligosaccharides and lactulose inhibut intestinal colonisation but stimulate translocation of salmonella in rats. Gut 52 (11), 1572-1578.
9. Boyd, J. F. (1985) Pathology of the alimentary tract in Salmonella typhimurium food poisoning. Gut 26 (9), 935-944.
10. Brück, W. M., Graverholt, G. and Gibson, G. R. (2002) Use of batch culture and a two-stage continuous culture system to study the effect of supplemental alpha-lactalbumin and glycomacropeptide on mixed populations of human gut bacteria. FEMS Microbiol. Ecol. 41, 231-237.
11. Brück, W. M., Graverholt, G. and Gibson, G. R. (2003a) A two-stage continuous culture system to study the effect of supplemental alpha-lactalbumin and glycomacropeptide on mixed cultures of human gut bacteria challenged with enteropathogenic Escherichia coli and Salmonella typhimurium. J. App. Microbiol. 95, 33-53.
12. Brück, W. M., Kelleher, S. L., Gibson, G. R., Nielsen, K. E., Chatterton, D. E.W. and Lönnerdal, B. (2003b) rRNA probes used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation of the predominant groups of intestinal bacteria of infant Rhesus monkeys challenged with enteropathogenic Escherichia coli. J. Pediatr. Gastroenterol. Nutr. 37, 273-280.
13. Camara, L. M., Carbonare, S. B., Silva, M. L. and Carneiro-Sampaio, M. M. (1994) Inhibition of enteropathogenic Escherichia coli (EPEC) adhesion to HeLa cells by human colostrum: detection of specific sIgA related to EPEC outer-membrane proteins. Int. Arch. Allergy Immunol. 103 (3), 307-310.
14. Campbell, M. A., Kolev, Y., Stahl, B., Boehm, G., Butler, R. N. and Stevenson, L. M. (2004) The role of oligosaccharides and Helicobacter pylori-specific antibodies in disease prevention. Asia Pac. J. Clin. Nutr. 13 (Suppl.), S92.
15. Castagliuolo, I., LaMont, J. T., Qiu, B., Nikulasson, S. T. and Pothoulakis, C. (1996) A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum. Gastroenterology 111 (2), 433-438.
16. CDC. (1991) Multistate outbreak of Salmonella poona infections: United States and Canada. Morbid Mortal Weekly Rep. 40, 549.
17. CDC. (1994) Salmonella Surveillance - Annual Summary - 1992. Centers for Disease Control and Prevention, Atlanta.
18. Chadwick, V. S. and Anderson, R. P. (1995) The role of intestinal bacteria in etiology and maintenance of inflammatory bowel disease. In Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology, G. R. Gibson, G. T. Macfarlane, Eds. CRC Press, Boca Raton, pp. 227-256.
19. Collins, M. D., Gibson, G. R. (1999) Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69 (Suppl.), 1052S-1057S.
20. Craviota, A., Tello, R. E. and Ortega, R. (1988) Prospective study of diarrhoeal disease in a cohort of rural Mexican children: incidence and isolated pathogens during the first two years. Epidemiol. Rev. 101, 123.
21. Darwin, K. H. and Miller, V. L. (1999) Molecular basis of the interaction of Salmonella with the intestinal mucosa. Clin. Microbiol. Rev. 12 (3), 405-428.
22. Donnenberg, M. S. (1995) Enteropathogenic Escherichia coli. In Infections of the Gastrointestinal Tract, M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg, R. L. Guerrant, Eds. Raven Press, New York, NY. pp. 709-726.
23. Felley, C. P., Corthesy-Theulaz, I., Rivero, J. L., Sipponen, P., Kaufmann, M., Bauerfeind, P., Wiesel, P. H., Brassart, D., Pfeifer, A., Blum, A. L. and Michetti, P. (2001) Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur. J. Gastroenterol. Hepatol. 13 (1), 25-29.
24. Figueroa-Quintanilla, E., Salazar-Lindo, E., Sack, R. B., Leon-Barua, S., Sarabia-Arce, S., Campos- Sanchez, M. and Eyzaguirre-Maccan, E. (1993) A controlled trial of bismuth subsalicylate in infants with watery diarrheal disease. N. Engl. J. Med. 328, 1653-1658.
25. Finlay, B. B. and Falkon, S. (1989) Common themes in microbial pathogenicity. Microbiol. Rev. 53, 210-230.
26. Floch, M. H. (2003) Probiotics, irritable bowel syndrome, and inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6 (4), 283-288.
27. Fuller, R. and Gibson, G. R. (1997) Modification of the intestinal microflora using probiotics and prebiotics. Scand. J. Gastroenterol. 222 (Suppl.), 28-31.
28. Gerards, C., Leodolter, A., Glasbrenner, B. and Malfertheiner, P. (2001) H. pylori infection and visceral hypersensitivity in patients with irritable bowel syndrome. Dig. Dis. 19 (2), 170-173.
29. Gibson, G. R. andWang, X. (1994) Regulatory effects of bifidobacteria in the growth of other colonic bacteria. J. Appl. Bacteriol. 77, 412-420.
30. Gibson, G. R. and Roberfroid, M. B. (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125 (6), 1401-1412.
31. Gibson, G. R., Beatty, E. R., Wang, X. and Cummings, J. H. (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology, 108 (4), 975-982.
32. Gibson, G. R., Saavedra, J. M., Macfarlane, S. and Macfarlane, G. T. (1997) Gastrointestinal Microbial Disease. In Probiotics 2: Application and Practical Aspects, R. Fuller, Ed. Chapman and Hall, Andover, pp. 10-39.
33. Gomez, H. F. and Cleary, G. G. (1998) Salmonella, 4th edn, Vol. 1. The EB Saunders Co., Philadelphia.
34. Grunfeld, C. and Feingold, K. (1992) Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N. Engl. J. Med. 327, 329-337.
35. Guandalini, S., Pensabene, L., Zikri, M. A., Dias, J. A., Casali, L. G., Hoekstra, H., Kolacek, S., Massar, K., Micetic-Turk, D., Papadopoulou, A., de Sousa, J. S., Sandhu, B., Szajewska, H. and Weizman, Z. (2000) Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trail. J. Pediatr. Gastroenterol. Nutr. 30 (1), 54-60.
36. Heerze, L. D., Kelm, M. A., Talbot, J. A. and Armstrong, G. D. (1994) Oligosaccharide sequences attached to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhea and pseudomembranous colitis. J. Infect. Dis. 169 (6), 1291-1296.
37. Hill, S. M., Philips, A. D. andWalker-Smith, J. A. (1991) Enteropathogenic Escherichia coli and lifethreatening chronic diarrhoea. Gut 32, 154-158.
38. Hopkins, M. J. and Macfarlane, G. T. (2003) Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro Appl. Environ. Microbiol. 69 (4), 1920-1927.
39. Ito, Y., Moriwaki, H., Muto, Y., Kato, N., Watanabe, K. and Ueno, K. (1997) Effect of lactulose on short-chain fatty acids and lactate production and on the growth of faecal flora, with special reference to Clostridium difficile.J. Med. Microbiol. 46 (1), 80-84.
40. Isolauri, E. (2001) Probiotics in the prevention and treatment of allergic disease. Pediatr. Allergy Immunol. 12 (Suppl. 14), 56-59.
41. Isolauri, E. (2004) Dietary modification of atopic disease: use of probiotics in the prevention of atopic dermatitis. Curr. Allergy Asthma Rep. 4 (4), 270-275.
42. Isolauri, E., Salminen, S. and Mattila-Sandholm, T. (1999a) New functional foods in the treatment of food allergy. Ann Med. 31 (4), 299-302.
43. Isolauri, E., Arvilommi, H. and Salminen, S. (1999b) Gastrointestinal infections. In Colonic Microbiota, Nutrition and Health, G. R. Gibson, M. B. Roberfroid, Eds. Kluwer Academic Publishers, Dordrecht, pp. 267-279.
44. Isolauri, E., Arvola, T., Sutas, Y., Moilanen, E. and Salminen, S. (2000) Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30, 1604-1610.
45. Kalliomaki, M., Kirjavainen, P., Eerola, E., Kero, P., Salminen, S. and Isolauri, E. (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107 (1), 129-134.
46. Karlsson, K.-A. (1989) Animal glycosphingolipids as membrane attachment sites for bacteria. Ann. Rev. Biochem. 58, 309-350.
47. Kawakami, H. (1997) Biological significance of sialic acid-containing substances in milk and their application. Recent Res. Dev. Agric. Biol. Chem. 1, 193-208.
48. Kawasaki, Y., Isoda H., Tanimoto, M., Dosako, S., Idota, T. and Ahiko, K. (1992) Inhibition by lactoferrin and k-casein glycomacropeptide of binding of Cholera toxin to its receptor. Biosci. Biotech. Biochem. 56, 195-198.
49. Kawasaki, Y., Isoda, H., Shinmoto, H., Tanimoto, M., Dosako, S., Idota, T. and Nakajima, I. (1993) Inhibition by k-casein glycomacropeptide and lactoferrin of influenza virus hemaglutination. Biosci. Biotech. Biochem. 57, 1214-1215.
50. Kelleher, S. L. and Lönnerdal, B. (2001) Immunological activities associated with milk. Adv. Nutr. Res. 10, 39-65.
51. Kim, H. J., Camilleri, M., McKinzie, S., Lempke, M. B., Burton, D. D., Thomforde, G. M. and Zinsmeister, A. R. (2003) A randomized controlled trail of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 17 (7), 895-904.
52. Kleessen, B., Bunke, H., Tovar, K., Noak, J. and Sawatzki, G. (1995) Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatr. 84, 1347-1356.
53. Kleessen, B., Stoof, G., Prol, J., Schmiedl, D., Noack, J. and Blaut, M. (1997) Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats. J anim. Sci. 75 (9), 2453-2462.
54. Kolida, S., Tuohy, K. and Gibson, G. R. (2002) Prebiotic effects of inulin and oligofructose. Br. J. Nutr. 87 (suppl. 2), S193-S197.
55. Lahdevirta, J., Maury, C. P. J., Teppo, A. M. and Repo, H. (1988) Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85, 289-291.
56. Levine, M. M. and Edelman, R. (1984) Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhoea: epidemiology and pathogenesis. Epideniol. Rev. 6, 31-51.
57. Levine, M. M., Bergquist, E. J., Nalin, D. R.,Waterman, D. H., Hornick, R. B., Young, C. R., Sotman, S. and Rowe, B. (1978) Escherichia coli that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet 1, 1119-1122.
58. Liehr, H., Englisch, G. and Rasenack, U. (1980) Lactulose - a drug with antiendotoxin effect. Hepatogastroenterology 27 (5), 356-360.
59. Majamaa, H. and Isolauri, E. (1996) Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J. Allergy Clin. Immunol. 97, 985-990.
60. Martinez, F. D. (1994) Role of viral infections in the inception of asthma and allergies during childhood: could they be protective? Thorax 49 (12), 1189-1191.
61. Mathew, M., Mathan, M. M., Mani, K., George, R., Jebakumar, K., Dharamsi, R., Kirubakaran, C., Pereira, S. and Mathan, V. I. (1991) The relationship of microbial pathogens to acute infectious diarrhoea of childhood. J. Trop. Med. Hyg. 94 (4), 253-260.
62. Matricardi, P. M., Rosmini, F., Riondino, S., Fortini, M., Ferrigno, L., Rapicetta, M. and Bonini, S. (2000) Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. Br. Med. J. 320 (7232), 412-417.
63. McKendrick, M. W. and Read, N. W. (1994) Irritable bowel syndrome-post salmonella infection. J. Infect. 29 (1), 1-3.
64. Michetti, P., Dorta, G., Wiesel, P. H., Brassart, D., Verdu, E., Herranz, M., Felley, C., Porta, N., Rouvet, M., Blum, A. L. and Corthesy-Theulaz, I. (1999) Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 60 (3), 203-209.
65. Nataro, J. P. and Kaper, J. B. (1998) Diarrheagic Escherichia coli. Clin. Microbiol. Rev. 11, 142-201.
66. Neal, K. R., Hebden, J. and Spiller, R. (1997) Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients Br. Med. J. 314, 779-782.
67. Newburg, D. S. (1997) Do the binding properties of oligosaccharides in milk protect human infants from gastrointestinal bacteria? J Nutr. 127 (5 Suppl.), 980S-984S.
68. Nzegwu, H. C. and Levin, R. C. (1994) Neutrally maintained hypersecretion in undernourished rat intestine activated by E.coli STa enterotoxin and cyclic nucleotides in vitro. J. Physiol. (London) 479, 159-169.
69. Oberhelman, R. A., Gilman, R. H., Sheen, P., Taylor, D. N., Black, R. E., Cabrera, L., Lescano, A. G., Meza, R. and Madico, G. (1999) A placebo-controlled trail of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children J. Pediatr. 134 (1), 15-20.
70. Olesen, M., Gudmand-Hoyer, E. (2000) Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am. J. Clin. Nutr. 72 (6), 1570-1575.
71. Parker, N., Tsai, H. H., Ryder, S. D., Raouf, A. H. and Rhodes, J. M. (1995) Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion 56 (1), 52-56.
72. Pelligrini, A., Thomas, U., Bramaz, N., Hunziker, P. and von Fellenberg, R. (1999) Isolation and identification of three bactericidal domains in the bovine alpha-lactalbumin molecule. Biochim. Biophys. Acta 1426 (3), 439-448.
73. Pihlanto-Leppälä, A., Marnila, P., Hubert, L., Rokka, T., Korhonen, H. J. T. and Karp, M. (1999) The effect of -lactalbumin and β-lactoglobulin hydrolysates on the metabolic activity of Escherichia coli JM103. J. Appl. Microbiol. 87: 540-545.
74. Qiao, H., Duffy, L. C., Griffiths, E., Dryja, D., Leavens, A., Rossman, J., Rich, G., Riepenhoff-Talty, M. and Locniskar, M. (2002) Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements. Pediatr. Res. 51 (6), 750-755.
75. Reid, G., Sanders, M. E., Gaskins, H. R., Gibson, G. R., Mercenier, A., Rastall, R., Roberfroid, M., Rowland, I., Cherbut, C. and Klaenhammer, T. R. (2003) New Scientific paradigms for probiotics and prebiotics. J. Clin. Gastroenterol. 37 (2), 105-118.
76. Ribeiro Jr, H. (2000) Diarrheal disease in a developing nation. Am. J. Gastroenterol. 95 (Suppl.), S14-S15.
77. Roberfroid, M. B. (2001) Prebiotics: preferential substrates for specific germs? Am. J. Clin. Nutr. 73 (Suppl.), 406S-409S.
78. Robins-Browne, R. M., Still, C. S., Miliotis, M. D., Richardson, N. J., Koornhof, H. J., Freiman, I., Schoub, B. D., Lecatsas, G. and Hartman, E. (1980) Summer diarrhoea in African infants and children. Arch. Dis. Child. 55 (12), 923.
79. Rodríguez, L. A. and Ruigómez, A. (1999) Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. Br. Med. J. 318, 565-566.
80. Rolfe, R. D. (2000) The role of probiotic cultures in the control of gastrointestinal health. J. Nutr. 130 (2S Suppl.), 396S-402S.
81. Saavedra, J. M., Bauman, N. A., Oung, I., Perman, J. A. and Yolken, R. H. (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344, 1046-1049.
82. Saggioro, A. (2004) Probiotics in the treatment of irritable bowel syndrome. J. Clin. Gastroenterol. 38 (6 Suppl.), S104-S106.
83. Saito, T., Miyakawa, H., Tamura, Y., Shimamura, S. and Tomita, M. (1991) Potent bactericidal activity of bovine lactoferrin hydrolysates produced by heat treatment at acidic pH. J. Dairy Sci. 74, 3724-3730.
84. Salminen, S., Bouley, C., Boutron-Ruault, M.-C., Cummings, J. H., Franck, A., Gibson, G. R., Isolauri, E., Moreau, M.-C., Roberfroid, M. and Rowland, I. (1998) Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80 (Suppl. 1), S147-S171.
85. Sartor, R. B. (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126 (6), 1620-1633.
86. Schmidt, W.-P. (2004) Model of the epidemic of childhood atopy. Med. Sci. Monit. 10 (2), HY5-HY9.
87. Singh, R. D., Khullar, M., Ganguly, N. K. (2000) Role of anaerobiosis in virulence of Salmonella typhimurium. Mol. Cell. Biochem. 215, 39-46.
88. Snoeyenbos, G. H., Smyser, C. F. and Van Roekel, H. (1969) Salmonella infections of the ovary and peritoneum of chickens. Avian Dis. 13, 668-670.
89. Stalheim-Smith, A. and Fitch, G. K. (1993) Understanding Human Anatomy and Physiology. West Publishing Company, St. Paul, pp. 783-844.
90. Steer, T., Carpenter, H., Tuohy, K. and Gibson, G. R. (2000) Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutr. Res. Rev. 13, 229-254.
91. Stromqvist, M., Falk, P., Bergstrom, S., Hansson, L., Lonnerdal, B., Normark, S. and Hernell, O. (1995) Human milk kappa-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa. J. Pediatr. Gastroenterol. Nutr. 21 (3), 288-296.
92. Szajewska, H. and Mrukowicz, J. Z. (2001) Probiotics in the treatment and prevention of acute infections diarrhea in infants and children: a systematic review of published randomized, doubleblind, placebo-controlled trails. J. Pediatr. Gastroenterol. Nutr. 33 (Suppl.), S17-S25.
93. Tannock, G. W. (1998) Studies of the intestinal microflora: a prerequisite for the development of probiotics. Int Dairy J. 8, 527-533.
94. Tauxe, R. V. and Pavia, A. T. (1998) Salmonellosis: nontyphoidal. In Bacterial Infections of Humans, Epidemiology and Control, A. S. Evans, P. S. Brachman, Eds. Plenum Medical Book Co., New York, pp. 223-242.
95. Ten Bruggencate, S. J., Bovee-Oudenhoven, I. M., Lettink-wissink, M. L. and Van der Meer, R. (2003) Dietary fructo-oligosaccharides dose-dependently increase translocation of salmonella in rats. J. Nutr. 133 (7), 2313-2318.
96. Thornley, J. P., Jenkins, D., Neal, K., Wright, T., Brough, J. and Spiller, R. C. (2001) Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J. Infect. Dis. 184 (5), 606-609.
97. Tuohy, K. M., Kolida, S., Lustenberger, A. M. and Gibson, G. R. (2001) The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides - a human volunteer study. Br. J. Nutr. 86 (3), 341-348.
98. Van Loo, J. A. E., Coussement, P., De Leenheer, L., Hoebregs, H. and Smits, G. (1995) On the presence of inulin and oligofructose as natural ingredients in theWestern diet. CRC Cri. Rev. Food Sci. Nutr. 35: 525-552.
99. Wang, X., Hirmo, S.,Willen, R. andWadstrom, T. (2001) Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model. J. Med. Microbiol. 50 (5), 430-435.
100. Willis, C. L. and Gibson, G. R. (1999) The natural microflora of humans. In Encyclopedia of Food Microbiology, R. Robinson, C. Batt, P. Patel, Eds. Academic Press, London, pp. 1351-1355.
101. Wilson, R., Feldman, R. A., Davis, J. and LaVenture, M. (1982) Salmonellosis in infants: the importance of intrafamilial transmission. Pediatrics 69, 436-438.
102. Wold, A. E. and Adlerberth, I. (2000) Breast-feeding and the intestinal microflora of the infant - implications for protection against infectious diseases. In Short and Long Term Effects of Breast Feeding on Child Health, B. Keletzo et al., Eds. Kluwer Academic/Plenum Publishers, Dordrecht, pp. 77-93.
103. Xue, Y., Lui, J. N., Sun, Z., Ma, Z., Wu, C. and Zhu, D. (2001) α-Lactalbumin mutant acting as lysozyme. Proteins: Struct. Funct. Genet. 42, 17-22.
104. Ziemer, C. J. and Gibson, G. R. (1998) An overview of probiotics, prebiotics and synbiotics in the functional food concept: perspectives and future strategies. Int. Dairy J. 8, 473-479.